Rare diseases
Investigational molecules
Locations
Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome
NorwayStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
NorwayStudy of Daratumumab Injections for Patients with Moderate to Severe Chronic Fatigue Syndrome
NorwayStudy of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms
NorwayStudy on Botulinum Toxin Type A for Patients with Treatment-Resistant Chronic Migraine
NorwayStudy on Dostarlimab, Carboplatin, and Paclitaxel for Patients with Recurrent or Advanced Endometrial Cancer
NorwayStudy on Treatment for Colorectal Liver Metastases Using Heparin, Dexamethasone, and Floxuridine for Patients with Heavy Tumor Burden
NorwayStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
NorwayStudy Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant
NorwayStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
NorwayStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
NorwayStudy on Human Normal Immunoglobulin to Prevent Early Infections in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
NorwayTell us about your condition – we search every trial in Europe and connect you with the right site.
